{
  "meta": {
    "title": "Insulin_Biguanides_Oha_Glp-1_Dpp4_Glucocorticoids_Mineralocorticoids",
    "url": "https://brainandscalpel.vercel.app/insulin-biguanides-oha-glp-1-dpp4-glucocorticoids-mineralocorticoids-ad2b2812.html",
    "scrapedAt": "2025-11-30T08:50:57.581Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Glyburide</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Repaglinide</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old obese woman in her 26th week of pregnancy was diagnosed with gestational diabetes mellitus after a positive glucose tolerance test. Dietary management failed to control the blood glucose, and her physician decided to prescribe an anti-diabetic therapy. Which of the following drugs would be most appropriate for the patient at this time?</span></p>",
      "unique_key": "DT1293210",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293210,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Gestational diabetes mellitus is defined as any glucose intolerance that develops or is recognized during pregnancy, regardless of severity or time of onset.</li>\r\n<li>Most gestational diabetics can control their glucose level with diet and regular exercise; drug therapy is needed only if these procedures are failing, as in this case.</li>\r\n<li>Insulin is the hypoglycemic drug of choice during pregnancy because it does not cross the placenta and has an established safety record for both mother and fetus.</li>\r\n</ul>\r\n<p><strong>Indications of insulin</strong></p>\r\n<ol>\r\n<li>All patients of type 1 DM</li>\r\n<li>Uncontrolled patients of type 2 DM</li>\r\n<li>Diabetes in pregnancy</li>\r\n<li>Diabetic Ketoacidosis</li>\r\n</ol>\r\n<ul>\r\n<li>Insulin is effective in all forms of diabetes mellitus and is a must for type 1 cases, as well as for post pancreatectomy diabetes and gestational diabetes.</li>\r\n<li>Many type 2 cases can be controlled by lifestyle measures like diet, reduction in body weight and appropriate exercise supplemented, if required, by oral antidiabetics.</li>\r\n</ul>\r\n<p><strong>Insulin is needed by such patients when:</strong></p>\r\n<ul>\r\n<li>Not controlled by diet and exercise or when these are not practicable.</li>\r\n<li>Primary or secondary failure of oral antidiabetics or when these drugs are not tolerated.</li>\r\n<li>Underweight patients.</li>\r\n<li>Temporarily to tide over infections, trauma, surgery, pregnancy. In the perioperative period and during labour, monitored i.v. insulin infusion is preferable.</li>\r\n<li>Any complication of diabetes, e.g. ketoacidosis, nonketotic hyperosmolar coma, gangrene of extremities.</li>\r\n</ul>\r\n<p><strong>Option A, B &amp; C:</strong> All of these agents are not preferred in Gestational diabetes.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Insulin is the hypoglycemic drug of choice during pregnancy because <strong>it does not cross the placenta and has an established safety record </strong>for both mother and fetus.</li>\r\n</ul>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Saxagliptin</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Metoprolol</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Linagliptin</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 75-year-old male patient has a known case of type-II diabetes mellitus and mild hypertension. He was taking several medicines for above mentioned conditions presented to the emergency department with septic shock following disseminated infection. His serum creatinine levels were 7.9 mg/dL with creatinine clearance <45 ml/min. Which of the following drugs should be stopped immediately?</span></p>",
      "unique_key": "DT1293215",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293215,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><u>Metformin should be avoided in the following patients because of risk of lactic acidosis</u>:\r\n<ul>\r\n<li>Renal disease</li>\r\n<li>Liver disease</li>\r\n<li>COPD</li>\r\n<li>Heart failure</li>\r\n<li>Elderly</li>\r\n</ul>\r\n</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412236c8c0a3c-9ddb-4733-b88a-f7fce1650aa1.jpg\">\r\n<p><strong>Option A &amp; C:</strong> Amongst DPP-4 inhibitors saxagliptin is avoided in renal failure but linagliptin can be safely given</p>\r\n<p><strong>Option B:</strong> Metoprolol is majorly excreted via hepatic route</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Metformin should be avoided in the patients with renal disease because of risk of lactic acidosis</li>\r\n</ul>",
      "correct_choice_id": 14,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin detemir</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">NPH insulin</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Repaglinide</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin aspart</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female with a past history of type II diabetes mellitus presents for routine follow-up. Her fasting blood sugars are controlled in the 80-100 mg/dl range. However, on your lab report the hemoglobin A1c (HBA1c) is elevated at 8.5. She is already on an oral biguanide and oral sulfonylurea. Which of the following agents would help with her prandial or mealtime glucose control without persisting in her system to cause later hypoglycemia?</span></p>",
      "unique_key": "DT1293217",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293217,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Insulin aspart is a rapid acting insulin ideal for mealtime glucose control as its onset is 5-15 minutes and duration is on average 2-3 hours.</li>\r\n<li>NPH and detemir insulin have longer durations of action and may combine with the oral sulfonylurea</li>\r\n<li><strong>Insulin lispro is a rapid-acting insulin that has an onset of action within 15 to 30 minutes.</strong></li>\r\n<li>Rapid-acting insulins are administered to mimic the prandial (mealtime) release of insulin and control postprandial glucose levels.</li>\r\n<li><strong>Insulin degludec is a long-acting insulin used to control fasting glucose levels.</strong></li>\r\n<li>NPH insulin is an intermediate-acting insulin also used for basal (fasting) control.</li>\r\n<li><strong>NPH/regular 70/30 insulin is a mixture of NPH (intermediate-acting) and regular (short-acting) insulin.</strong></li>\r\n<li>The patient is already on a long-acting insulin (detemir) for basal control, and another insulin for basal control is not warranted.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223d68a662d-f63a-4f27-92c3-43301166af1e.jpg\">\r\n<p><strong>Option A &amp; B:</strong> NPH and detemir insulin have longer durations of action and may combine with the oral sulfonylurea</p>\r\n<p><strong>Option C:</strong> Meglitinides have similar mechanism to cause release of insulin. Nateglinide and repaglinide are the drugs in this group. These drugs are used for the treatment of post prandial hyperglycemia due to their rapid onset and short duration of action</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Rapid-acting insulins are administered to mimic the prandial (mealtime) release of insulin and control postprandial glucose levels.</li>\r\n</ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Vildagliptin</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Linagliptin</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Saxagliptin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old patient presented to the medicine department with a history of having type-II diabetes mellitus and mild hypertension. He also had a history of having late stage chronic kidney disease. Which of the following anti-diabetic drugs is most suitable choice for this patient as it requires least dose modification in renal disease?</span></p>",
      "unique_key": "DT1293219",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293219,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>Gliptins (DPP - 4 inhibitors) are contraindicated in renal failure except Linagliptin which is safe in renal failure</p>\r\n<ul>\r\n<li>Alogliptin, saxagliptin, sitagliptin, and vildagliptin circulate primarily in unbound form and are excreted largely unchanged in the urine; lower doses should be given to patients with reduced renal function.</li>\r\n<li><strong>Linagliptin binds extensively to plasma proteins and is cleared primarily by the hepatobiliary system, with little renal clearance.</strong></li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122339cfa3e1-9c00-438e-8b4b-34ad66e751d0.jpg\"><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122304d795e8-b2c5-4f63-ba34-f8181eed723a.jpg\">\r\n<p><strong>Option A, B &amp; D:</strong> Gliptins (DPP - 4 inhibitors) such as Sitagliptin ,Vildagliptin &amp; Saxagliptin are contraindicated in renal failure except Linagliptin which is safe in renal failure.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Gliptins (DPP - 4 inhibitors) are contraindicated in renal failure except Linagliptin which is safe in renal failure</li>\r\n</ul>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Canagliflozin</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Rosiglitazone</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Voglibose</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Rapaglinide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female known case of type -II diabetes mellitus presented to ophthalmology department with complaints of decrease visual acuity after taking an anti-diabetic drug for some time. Fundus examination revealed features shown in the image below. Which of the following anti-diabetic drugs is implicated for the same?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223663d942e-ffa1-4b57-8576-4a229eb33bc2.jpg\"></span></p>",
      "unique_key": "DT1293220",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293220,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Rosiglitazone is a Thiazolidinediones group of antidiabetic drug leading to development of new onset or worsening of macular edema</strong></li>\r\n</ul>\r\n<ul>\r\n<li><strong>Thiazolidinediones</strong>\r\n<ul>\r\n<li>Troglitazone, pioglitazone and rosiglitazone are the drugs in this group that act as agonists of a nuclear receptor; peroxisome proliferator activated receptor gamma (PPAR&gamma;).</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<ul>\r\n<li>It regulates the transcription of genes involved in glucose and lipid metabolism. Important genes that are up regulated by PPAR-&gamma; are:\r\n<ul>\r\n<li>Adiponectin</li>\r\n<li>Fatty acid transport protein</li>\r\n<li>Insulin receptor substrate</li>\r\n<li>GLUT - 4</li>\r\n</ul>\r\n</li>\r\n</ul>\r\n<ul>\r\n<li>These drugs are used to reverse insulin resistance in type II DM. These drugs also tend to increase HDL.</li>\r\n</ul>\r\n<ul>\r\n<li>Troglitazone was withdrawn due to serious hepatotoxicityand monitoring of hepatic function is recommended for other glitazones also.</li>\r\n</ul>\r\n<ul>\r\n<li>Glitazones have been reported to cause weight gain, edema and plasma volume expansion. Therefore, these should be avoided in CHF patients. (NYHA class III and IV)</li>\r\n</ul>\r\n<p><strong>Rosiglitazone</strong> increases total and LDL cholesterol as well as HDL-cholesterol whereas pioglitazone increases HDL-cholesterol without affecting total and LDL-cholesterol. So, pioglitazone is the preferred agent from this group.</p>\r\n<p><strong>There were concerns of Pioglitazone</strong> to be associated with <strong>increased risk of bladder cancer</strong> on long term use.</p>\r\n<p><strong>Both of these</strong> can result in:</p>\r\n<ul>\r\n<li>Weight gain</li>\r\n<li>Edema</li>\r\n<li><strong>New onset or worsening of macular edema</strong></li>\r\n<li>Increase in fracture risk in women</li>\r\n<li>Anemia</li>\r\n</ul>\r\n<p><strong>Option A:</strong> Dapagliflozin, empagliflozin, ertugliflozin and canagliflozin act by inhibiting this transporter (sodium glucose co-transporter-2 [SGLT-2] and cause glucosuria in diabetics. These also result in weight loss. Main adverse effects are increased incidence of urinary tract infections and genital infections. SGLT-2 inhibitors cause a decrease in bone mineral density and increase risk of fractures</p>\r\n<p><strong>Option C: </strong>&alpha; glucosidase Inhibitors are acarbose, voglibose and miglitol, which decrease carbohydrate absorption from the GIT.</p>\r\n<p>Major adverse effect of these drugs is flatulence due to fermentation of unabsorbed carbohydrates. (therefore, contra-indicated in inflammatory bowel disease) These do not cause hypoglycemia.</p>\r\n<p><strong>Option D:</strong> Meglitinides have similar mechanism to cause release of insulin. Nateglinide and repaglinide are the drugs in this group. These drugs are used for the treatment of post prandial hyperglycemia due to their rapid onset and short duration of action. These drugs can also result in hypoglycemic episodes and weight gain.</p>\r\n<p><strong>Key Takeaway</strong></p>\r\n<ul>\r\n<li>Rosiglitazone is a Thiazolidinediones group of antidiabetic drug leading to development of new onset or worsening of macular edema</li>\r\n</ul>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Voglibose</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Vildagliptin</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Glipizide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old patient of type 2 diabetes mellitus was controlled on oral hypoglycemic drugs. This patient presented to the hospital with profuse sweating and dizziness. There was the presence of hypoglycemia. Which among the following drugs can result in hypoglycemia in this patient?</span></p>",
      "unique_key": "DT1293222",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293222,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223ea6a8a85-414e-4f7e-8175-34aa456d125a.jpg\"><p><strong>Option A, B &amp; C:</strong> All these agents don't cause hypoglycaemia rather, they are anti-hypertensive agents.</p>\r\n<p><strong><u>Key Takeaway</u></strong></p>\r\n<ul>\r\n<li>Sulfonylureas can cause weight gain and hypoglycaemia.</li>\r\n</ul>",
      "correct_choice_id": 54,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Biguanides</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulphonylureas</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Meglitinides</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">SGLT2 inhibitors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old young female with a history of type-II diabetes mellitus presented to medicine department with complaints of repetitive genital mycotic infection. Which of the following group of oral anti-diabetic drug is most commonly associated with genital mycotic infections as frequent side effects?</span></p>",
      "unique_key": "DT1293223",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293223,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Adverse Effects of SGLT2 inhibitors</strong></p>\r\n<ul>\r\n<li>The side effects of SGLT2 inhibitors are predictable from their mechanism of action.</li>\r\n<li>There is a small (1%-2%) increase in lower urinary tract infections and a 3%-5% increase in genital mycotic infections.</li>\r\n<li>SGLT2 inhibitors do not cause hypoglycemia but can increase that likelihood when combined with drugs that do.</li>\r\n<li>Recent analyses of clinical trials with SGLT inhibitors suggested that they may increase the risk of fractures(FDA warning)</li>\r\n<li>There have been rare cases of diabetic ketoacidosis reported in patients treated with SGLT2 inhibitors.</li>\r\n<li><strong>Canagliflozin is associated with an increased risk of lower extremity amputation.</strong></li>\r\n</ul>\r\n<p><strong>Option A: </strong>Metformin should be avoided in the patients with renal disease because of risk of lactic acidosis</p>\r\n<p><strong>Option B:</strong> Sulfonylureas can cause weight gain and hypoglycaemia</p>\r\n<p><strong>Option C: </strong>Meglitinides have similar mechanism to cause release of insulin. Nateglinide and repaglinide are the drugs in this group. These drugs can also result in hypoglycemic episodes and weight gain.</p>\r\n<p><strong>Key Takeaway</strong></p>\r\n<ul>\r\n<li>Main adverse effects are increased incidence of urinary tract infections and genital infections. SGLT-2 inhibitors cause decrease in bone mineral density and increase risk of fractures</li>\r\n</ul>",
      "correct_choice_id": 64,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase insulin sensitivity in adipose and muscle</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase insulin secretion from &beta;-cells</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease somatostatin release from &delta;-cells</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Decrease glucose absorption in the small intestine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old male with type II diabetes is taking glimepiride for his disease but is not maintaining adequate glycemic control with an HbA1c level of 7.3%. His physician has advised to add a thiazolidinediones group of drug to his existing medications. Thiazolidinediones group of drug acts by which of the following mechanism?</span></p>",
      "unique_key": "DT1293225",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293225,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p>The major mechanism of action of thiazolidinediones is increasing sensitivity to insulin in adipose, skeletal muscle, and liver.</p>\r\n<p>Several classes of hypoglycaemic drugs act to increase insulin release from the pancreas including the</p>\r\n<ul>\r\n<li>Sulfonylureas,</li>\r\n<li>Incretins, and</li>\r\n<li>Dpp-iv antagonists.</li>\r\n</ul>\r\n<p>This class of oral antidiabetic drugs are selective agonists for the nuclear peroxisome proliferator-activated receptor &gamma; (PPAR&gamma;) which is expressed mainly in fat cells, but also in muscle and some other cells.</p>\r\n<p><strong>Pioglitazone enhances the transcription of several insulin responsive genes and tends to reverse insulin resistance by enhancing GLUT4 expression and translocation.</strong></p>\r\n<p>Entry of glucose into muscle and fat is improved; the primary action is to enhance peripheral insulin sensitivity.</p>\r\n<p>Hepatic gluconeogenesis is also suppressed.</p>\r\n<p>Activation of genes regulating fatty acid metabolism and lipogenesis in adipose tissue contributes to the insulin sensitizing action.</p>\r\n<p>Lipolysis and plasma fatty acid levels are reduced.</p>\r\n<p><strong>Adipocyte turnover and differentiation is accelerated by glitazones.</strong></p>\r\n<p>Thus, fatty tissue is a major site of their action.</p>\r\n<p><strong>Option B:</strong> Sulphonylureas acts via Increase insulin secretion from &beta;-cells</p>\r\n<p><strong>Option C:</strong> Octreotide Decrease somatostatin release from &delta;-cells</p>\r\n<p><strong>Option D:</strong> Decrease glucose absorption in the small intestine is not a major MOA of Any drug.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>The major mechanism of action of thiazolidinediones is increasing sensitivity to insulin in adipose tissue, skeletal muscle, and liver.</li>\r\n</ul>",
      "correct_choice_id": 71,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">C</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 11-year-old boy recently diagnosed with type 1 diabetes started insulin therapy by his physician. Which of the following insulin regimens (Given in the table below) would be the most appropriate for long term therapy of this boy's condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412237b8a7db6-81bc-46cc-836f-c95c1bed346f.jpg\"></span></p>",
      "unique_key": "DT1293226",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293226,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Endocrinologists have developed a variety of insulin regimens that areintended to mimic the release of insulin from the pancreas.</li>\r\n<li>The general goal of these insulin regimens is to provide a basal level of insulin over 24 hours and to supply additional mealtime insulin coverage.</li>\r\n<li>This can be done by administering a rapid-acting insulin at meals and a longacting insulin at bedtime to ensure basal coverage for the following 24 hours.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223b81eb507-db99-4733-bd78-9ea4692e7a71.jpg\">\r\n<p><strong>Option B:</strong> A regular insulin at breakfast cannot supply a basal level of insulin over 24 hours.</p>\r\n<p>Moreover, rapid-acting insulins such as lispro are given to control postprandial hyperglycemia; administration at bedtime is irrational.</p>\r\n<p><strong>Option C:</strong> NPH (neutral protamine Hagedorn) insulin at breakfast and lunch can supply a basal level of insulin over 24 hours but cannot control postprandial hyperglycemia.</p>\r\n<p><strong>Option D:</strong> This regimen cannot provide a basal level of insulin over 24 hours.</p>\r\n<p><strong>Key Takeaway</strong></p>\r\n<ul>\r\n<li>Under Basal bolus regimen a long-acting insulin (glargine) is injected once daily either before breakfast or before bed-time for basal coverage along with 2-3 meal-time injections of a rapid acting preparation (insulin lispro or aspart).</li>\r\n</ul>",
      "correct_choice_id": 81,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Acarbose</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Sitagliptin</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Repaglinide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 57-year-old obese man was diagnosed with type 2 diabetes mellitus. The patient had been suffering from chronic obstructive pulmonary disease for 5 years and from hypertension for 3 years. His current therapy included ipratropium and captopril. Which of the following antidiabetic drugs would be relatively contraindicated in this patient?</span></p>",
      "unique_key": "DT1293227",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293227,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Biguanides can cause lactic acidosis and therefore are relatively contraindicated in all conditions that predispose to acidosis.</li>\r\n<li>This patient is suffering from chronic obstructive pulmonary disease and is under treatment with an angiotensin-converting enzyme (ACE) inhibitor.</li>\r\n<li>The respiratory disease predisposes to respiratory acidosis, and ACE inhibitors predispose to metabolic acidosis because they lower aldosterone serum levels.</li>\r\n<li>Metformin should be avoided in the following patients because of risk of lactic acidosis:\r\n<ul>\r\n<li>Renal disease</li>\r\n<li>Liver disease</li>\r\n<li>COPD</li>\r\n<li>Heart failure</li>\r\n<li>Elderly</li>\r\n</ul>\r\n</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412234c40d2b1-69fd-4fc6-90d2-79f9dc32d628.jpg\">\r\n<p><strong>Option A, C &amp; D:</strong> All of them can be safely given in patients with COPD.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Biguanides can cause lactic acidosis and therefore are relatively contraindicated in all conditions that predispose to acidosis.</li>\r\n</ul>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">B</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">C</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old woman with a long history of severe type 2 diabetes had been taking multiple daily injections of insulin, including an insulin glargine preparation. Which of the following sets of properties (Given in the table below) best describes the time course of effects of this preparation?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223c1bab6bb-5b58-4a0a-9feb-652993ef3ca9.jpg\"></span></p>",
      "unique_key": "DT1293228",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293228,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Insulin glargine is a long-acting insulin analogue that was designed to provide a broad plasma concentration plateau.</li>\r\n<li>It has an onset of action of 1 to 4 hours, achieves a maximum effect after 4 to 6 hours, and can maintain this effect for over 24 hours.</li>\r\n<li>It is usually given once daily to provide basal levels of insulin.</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202412236618d567-fdb8-4fb5-96a5-235c86d1e74a.jpg\">\r\n<p><strong>Option A : SemiLente insulin Shows this type of pharmacokinetic. </strong></p>\r\n<p><strong>Option B &amp; C : These pharmacokinetic data matches with short acting insulin like lispro, aspart and glulisine.</strong></p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Insulin glargine is a long-acting insulin analogue, it has an onset of action of 1 to 4 hours, achieves a maximum effect after 4 to 6 hours, and can maintain this effect for over 24 hours.</li>\r\n</ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Fludrocortisone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Triamcinolone</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young patient with Addison's disease continues to have hyperkalemia despite receiving adequate replacement doses of hydrocortisone (cortisol). Which of the following drug should be added to the treatment regimen to reduce serum potassium levels?</span></p>",
      "unique_key": "DT1293229",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293229,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Fludrocortisone is approximately 100 times more potent as a mineralocorticoid than is cortisoland is the most potent mineralocorticoid available for clinical use.</li>\r\n<li>It acts to increase sodium retention and potassium excretion, thereby lowering serum potassium levels.</li>\r\n</ul>\r\n<p>Chronic adrenal insufficiency (Addison's disease)</p>\r\n<ul>\r\n<li>Hydrocortisone given orally is the most commonly useddrug along with adequate salt and water allowance.</li>\r\n<li>Some patients who continue to excrete excess Na+ need additionalmineralocorticoid: fludrocortisone is added.</li>\r\n</ul>\r\n<p><strong>Fludrocortisone </strong></p>\r\n<p>A potent mineralocorticoid having some glucocorticoid activity as well, orally active, used for following disorders</p>\r\n<ul>\r\n<li>Replacement therapy in Addison's disease</li>\r\n<li>Congenital adrenal hyperplasia in patients with salt wasting</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223ea39b417-9121-4d50-8bc0-d3abd7fd2f0b.jpg\">\r\n<p><strong>Option A, C &amp; D:</strong> All agents have very weak to nil mineralocorticoid activity hence not preferred here.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Fludrocortisone is the most potent mineralocorticoid available for clinical use. It acts to increase sodium retention and potassium excretion, thereby lowering serum potassium levels.</li>\r\n</ul>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydrocortisone</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Potassium binding resin</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Calcium gluconate</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 18-month-old child presented to paediatric OPD with ambiguous genitalia, on investigation his BP is 110/70 mm Hg, Serum potassium is 6.5 mEq/L, serum sodium is 115 mEq/L. He was later started on intravenous fluids. What is the most specific therapy will you add to this patient immediately?</span></p>",
      "unique_key": "DT1293232",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293232,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Normal serum K+ level is 3.5-5.0 mEq/L. Normal Na+ level is 136-152 mEq/L. So, the patient in the question has hyperkalemia and hyponatremia.</li>\r\n<li>This together with ambiguous genitalia suggests the diagnosis of CAH (Congenital adrenal hyperplasia).</li>\r\n<li>In CAH, there is <strong>deficiency of glucocorticoids and mineralocorticoids</strong></li>\r\n<li>Hydrocortisone is the glucocorticoid with maximum mineralocorticoid activity, so it is the preferred drug for treatment of this patient.</li>\r\n</ul>\r\n<p><strong>Congenital adrenal hyperplasia (Adrenogenital syndrome) </strong></p>\r\n<ul>\r\n<li>It is a familial disorder due to genetic deficiency of steroidogenic enzymes, mostly 21-hydroxylase.</li>\r\n<li>As a result the synthesis of hydrocortisone and aldosterone suffers.</li>\r\n<li>There is compensatory increase in ACTH secretion causing adrenocortical hypertrophy.</li>\r\n<li>Enzyme deficiency being only partial in most cases, normal amounts of gluco- and mineralocorticoidsare produced along with excessive amounts of weak androgens which produce virilisation and/or precocious sexual development.</li>\r\n<li>Treatment is to give hydrocortisone in divided doses round the clock to maintain feedback suppression of pituitary.</li>\r\n<li>If salt wasting persists-fludrocortisone 50-200 &mu;g/day may be added.</li>\r\n</ul>\r\n<p><strong>Option B, C &amp; D:</strong> All agents given here are not used in Congenital adrenal hyperplasia</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Hydrocortisone is the glucocorticoid with maximum mineralocorticoid activity, hence preferred in cases with Congenital adrenal hyperplasia (CAH) where there is deficiency of glucocorticoids and mineralocorticoids</li>\r\n</ul>",
      "correct_choice_id": 121,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Paracetamol</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Prednisolone</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Metformin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old female named Shakti was suffering from systemic lupus erythematosus, for which she was prescribed medicine by a physician for the last 2 years. She later presented to medicine OPD with the features as side effects of ongoing medicine (shown in the below figure). Which of the following is the most likely drug a person has consumed?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250117ef762677-207a-4ea9-a887-6127a06d40a8.jpg\"></span></p>",
      "unique_key": "DT1293234",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293234,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li><strong>Side effects of shown in the figure above due to long term prednisolone therapy is depicted below</strong></li>\r\n</ul>\r\n<p><strong>Cushing's habitus:</strong> characteristic appearance with</p>\r\n<ul>\r\n<li>Rounded face</li>\r\n<li>Narrow mouth</li>\r\n<li>Supraclavicular hump</li>\r\n<li>Obesity of trunk with relatively thin limbs</li>\r\n</ul>\r\n<p><strong>Fragile skin, purple striae-typically on thighs and lower abdomen with</strong></p>\r\n<ul>\r\n<li>Easy bruising</li>\r\n<li>Telangiectasis</li>\r\n<li>Hirsutism</li>\r\n<li>Cutaneous atrophy</li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2024122386cb6641-892b-46dc-884d-0ff1e346ab40.jpg\">\r\n<p><strong>Option A, C &amp; D:</strong> Rest all agents given here are not associated with development of Cushing's habitus.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Long term prednisolone (Glucocorticoids) therapy is associated with development of Cushing's habitus.</li>\r\n</ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids inhibit both prostaglandin production and inflammatory cells</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids are more potent inhibitors of cyclooxygenase than naproxen</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids inhibit biosynthesis of both COX-1 and COX-2</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids will reduce the edema in the inflamed area</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old patient brought to the medicine department seeking treatment for severe shoulder pain resulting from long-term injury & inflammation which is not responding to treatment with naproxen. His physician has begun a course of treatment with oral dexamethasone. Which of the following provides the most appropriate basis that the glucocorticoid will be more effective as an anti-inflammatory agent than NSAIDs?</span></p>",
      "unique_key": "DT1293236",
      "question_audio": null,
      "question_video": null,
      "map_id": 1293236,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\r\n<li>Glucocorticoids reduce prostaglandin production like NSAIDs and theyalso inhibit most of the cells that are involved in the inflammatory process.</li>\r\n<li>Inflammatory responses Irrespective of the type of injury or insult, the attending inflammatory response is suppressed by glucocorticoids.</li>\r\n</ul>\r\n<p><strong>This includes attenuation of following</strong></p>\r\n<ul>\r\n<li>Increased capillary permeability</li>\r\n<li>Local exudation</li>\r\n<li>Cellular infiltration</li>\r\n<li>Phagocytic activity</li>\r\n<li>Late responses like capillary proliferation, collagen deposition, fibroblastic activity and ultimately scar formation.</li>\r\n</ul>\r\n<ul>\r\n<li><strong>Glucocorticoids interfere at several steps in the inflammatory response but the most important overall mechanism appears to be a limitation ofrecruitment of inflammatory cells at the local site and production of proinflammatory mediators like PGs, LTs, PAF through indirect inhibition of phospholipase A2.</strong></li>\r\n</ul><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20241223e6c0e52c-6538-4697-be7a-c573b7e7c3fb.jpg\">\r\n<p><strong>Option B:</strong> Naproxen and NSAID are more potent inhibitors of cyclooxygenase than Glucocorticoids.</p>\r\n<p><strong>Option C:</strong> Glucocorticoids inhibit biosynthesis COX-2.</p>\r\n<p><strong>Option D:</strong> Glucocorticoids will reduce the edema in the inflamed area however it's not major advantage over NSAIDS.</p>\r\n<p><strong>Key Takeaway:</strong></p>\r\n<ul>\r\n<li>Inflammatory responses Irrespective of the type of injury or insult, the attending inflammatory response is suppressed by glucocorticoids. Glucocorticoids reduce prostaglandin production like NSAIDs and they also inhibit most of the cells that are involved in the inflammatory process.</li>\r\n</ul>",
      "correct_choice_id": 141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}